Stockreport

Celularity to Present at Jefferies Cell and Genetic Medicine Summit

Celularity Inc. - Class A  (CELU) 
PDF FLORHAM PARK, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-deriv [Read more]